MedPath

Gabar Health Sciences Corp.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Drug Approvals

Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%

Approval Date
Jan 29, 2024
FDA

Sodium Sulfacetamide 10% and Sulfur 2% Cleanser

Approval Date
Jan 29, 2024
FDA

Sodium Sulfacetamide Wash 10%

Approval Date
Jan 29, 2024
FDA

Sodium Sulfacetamide Wash 10%

Approval Date
Jan 29, 2024
FDA

Sodium Sulfacetamide 9% and Sulfur 4% Cleanser

Approval Date
Jan 28, 2024
FDA

Diclofenac Sodium

Approval Date
Nov 28, 2023
FDA

Mupirocin

Approval Date
Nov 27, 2023
FDA

Mupirocin

Approval Date
Nov 27, 2023
FDA

Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser

Approval Date
Oct 21, 2023
FDA

UREA 40%

Approval Date
Oct 21, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.